IXICO PLC (IXI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
12.00p
Buy
12.50p
0.00p (+0.00%)
Prices updated at 12 Dec 2025, 15:33 GMT
| Prices minimum 15 mins delay
Prices in GBX
IXICO PLC is engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 48.71 |
| 2024 | 47.02 |
| 2023 | 49.06 |
| 2022 | 60.66 |
| 2021 | 65.55 |
| 2020 | 66.58 |
| 2019 | 65.36 |
| 2018 | 58.82 |
| 2017 | 56.44 |
| 2016 | 48.59 |
| 2015 | 57.53 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 1.68 |
| 2024 | 0.98 |
| 2023 | 0.91 |
| 2022 | 1.50 |
| 2021 | 3.29 |
| 2020 | 5.11 |
| 2019 | 5.60 |
| 2018 | 1.47 |
| 2017 | 2.39 |
| 2016 | 2.47 |
| 2015 | - |
Price/Forward earnings (YTD)
-13.32
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | -13.19 |
| 2024 | -16.55 |
| 2023 | -8.52 |
| 2022 | 7.14 |
| 2021 | 11.42 |
| 2020 | 8.30 |
| 2019 | 4.11 |
| 2018 | -9.00 |
| 2017 | -30.16 |
| 2016 | -42.72 |
| 2015 | -24.74 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 1.18 |
| 2024 | 1.18 |
| 2023 | 1.14 |
| 2022 | 1.17 |
| 2021 | 1.24 |
| 2020 | 1.30 |
| 2019 | 1.35 |
| 2018 | 1.41 |
| 2017 | 1.68 |
| 2016 | 1.47 |
| 2015 | 1.56 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
